Learn More

MedMorphIQ is a next-generation cancer diagnostics platform built to meet the precision and efficiency demands of modern pathology. The system offers an end-to-end workflow for biomarker quantification, combining intelligent auto-counting with expert-guided review to ensure clinical-grade reliability. Its outputs—cleanly formatted PDF and PNG reports—are optimized for integration into existing pathology systems, enabling rapid turnaround without disrupting established protocols. While currently specialized in Ki-67 indexing for tumor proliferation assessment, MedMorphIQ is designed to scale, with future support planned for additional biomarkers and histopathological applications across a wide range of cancer types.